Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Clinical Trial Packaging Market by Type (Syringes, Vials and Ampoules, Blisters, Tubes, Bottles, Bags and Pouches, Sachets, Kits or Packs, Others), By Application (Drug Manufacturing Companies, Research Laboratories, Clinical Research Organizations) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Clinical Trial Packaging Market by Type (Syringes, Vials and Ampoules, Blisters, Tubes, Bottles, Bags and Pouches, Sachets, Kits or Packs, Others), By Application (Drug Manufacturing Companies, Research Laboratories, Clinical Research Organizations) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 318717 4200 Medical Care 377 161 Pages 4.8 (48)
                                          

Industry Growth Insights published a new data on “Clinical Trial Packaging Market”. The research report is titled “Clinical Trial Packaging Market research by Types (Syringes, Vials and Ampoules, Blisters, Tubes, Bottles, Bags and Pouches, Sachets, Kits or Packs, Others), By Applications (Drug Manufacturing Companies, Research Laboratories, Clinical Research Organizations), By Players/Companies Bilcare, Fisher Clinical Services, WuXi AppTec, PCI Pharma Services, Almac Group, PharMaterials, PAREXEL, Schreiner MediPharm, Sharp Packaging, The Coghlan Group, Rubicon, Westrock, Xerimis, Catalent, Piramal Pharma Solutions, Corden Pharma, DMB Consultancy, Körber Medipak Systems, Sentry BioPharma, NextPharma, Mawdsleys”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Clinical Trial Packaging Market Research Report

By Type

Syringes, Vials and Ampoules, Blisters, Tubes, Bottles, Bags and Pouches, Sachets, Kits or Packs, Others

By Application

Drug Manufacturing Companies, Research Laboratories, Clinical Research Organizations

By Companies

Bilcare, Fisher Clinical Services, WuXi AppTec, PCI Pharma Services, Almac Group, PharMaterials, PAREXEL, Schreiner MediPharm, Sharp Packaging, The Coghlan Group, Rubicon, Westrock, Xerimis, Catalent, Piramal Pharma Solutions, Corden Pharma, DMB Consultancy, Körber Medipak Systems, Sentry BioPharma, NextPharma, Mawdsleys

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

161

Number of Tables & Figures

113

Customization Available

Yes, the report can be customized as per your need.


Global Clinical Trial Packaging Industry Outlook


Global Clinical Trial Packaging Market Report Segments:

The global Clinical Trial Packaging market is segmented on the basis of:

Types

Syringes, Vials and Ampoules, Blisters, Tubes, Bottles, Bags and Pouches, Sachets, Kits or Packs, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Drug Manufacturing Companies, Research Laboratories, Clinical Research Organizations

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Bilcare
  2. Fisher Clinical Services
  3. WuXi AppTec
  4. PCI Pharma Services
  5. Almac Group
  6. PharMaterials
  7. PAREXEL
  8. Schreiner MediPharm
  9. Sharp Packaging
  10. The Coghlan Group
  11. Rubicon
  12. Westrock
  13. Xerimis
  14. Catalent
  15. Piramal Pharma Solutions
  16. Corden Pharma
  17. DMB Consultancy
  18. Körber Medipak Systems
  19. Sentry BioPharma
  20. NextPharma
  21. Mawdsleys

Global Clinical Trial Packaging Market Overview


Highlights of The Clinical Trial Packaging Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Syringes
    2. Vials and Ampoules
    3. Blisters
    4. Tubes
    5. Bottles
    6. Bags and Pouches
    7. Sachets
    8. Kits or Packs
    9. Others
  1. By Application:

    1. Drug Manufacturing Companies
    2. Research Laboratories
    3. Clinical Research Organizations
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Clinical Trial Packaging Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Clinical Trial Packaging Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Clinical trial packaging is the way in which clinical trials are delivered to study participants. Clinical trial packages typically include information about the study, such as its purpose and how to participate, as well as a set of instructions for completing the study.

Some of the major players in the clinical trial packaging market are Bilcare, Fisher Clinical Services, WuXi AppTec, PCI Pharma Services, Almac Group, PharMaterials, PAREXEL, Schreiner MediPharm, Sharp Packaging, The Coghlan Group, Rubicon, Westrock, Xerimis, Catalent, Piramal Pharma Solutions, Corden Pharma, DMB Consultancy, K¶rber Medipak Systems, Sentry BioPharma, NextPharma, Mawdsleys.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Clinical Trial Packaging Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Clinical Trial Packaging Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Clinical Trial Packaging Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Clinical Trial Packaging Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Clinical Trial Packaging Market Size & Forecast, 2020-2028       4.5.1 Clinical Trial Packaging Market Size and Y-o-Y Growth       4.5.2 Clinical Trial Packaging Market Absolute $ Opportunity

Chapter 5 Global  Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2  Market Size Forecast by Type
      5.2.1 Syringes
      5.2.2 Vials and Ampoules
      5.2.3 Blisters
      5.2.4 Tubes
      5.2.5 Bottles
      5.2.6 Bags and Pouches
      5.2.7 Sachets
      5.2.8 Kits or Packs
      5.2.9 Others
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global  Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2  Market Size Forecast by Applications
      6.2.1 Drug Manufacturing Companies
      6.2.2 Research Laboratories
      6.2.3 Clinical Research Organizations
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Clinical Trial Packaging Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Clinical Trial Packaging Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America  Analysis and Forecast
   9.1 Introduction
   9.2 North America  Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America  Market Size Forecast by Type
      9.6.1 Syringes
      9.6.2 Vials and Ampoules
      9.6.3 Blisters
      9.6.4 Tubes
      9.6.5 Bottles
      9.6.6 Bags and Pouches
      9.6.7 Sachets
      9.6.8 Kits or Packs
      9.6.9 Others
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America  Market Size Forecast by Applications
      9.10.1 Drug Manufacturing Companies
      9.10.2 Research Laboratories
      9.10.3 Clinical Research Organizations
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe  Analysis and Forecast
   10.1 Introduction
   10.2 Europe  Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe  Market Size Forecast by Type
      10.6.1 Syringes
      10.6.2 Vials and Ampoules
      10.6.3 Blisters
      10.6.4 Tubes
      10.6.5 Bottles
      10.6.6 Bags and Pouches
      10.6.7 Sachets
      10.6.8 Kits or Packs
      10.6.9 Others
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe  Market Size Forecast by Applications
      10.10.1 Drug Manufacturing Companies
      10.10.2 Research Laboratories
      10.10.3 Clinical Research Organizations
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific  Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific  Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific  Market Size Forecast by Type
      11.6.1 Syringes
      11.6.2 Vials and Ampoules
      11.6.3 Blisters
      11.6.4 Tubes
      11.6.5 Bottles
      11.6.6 Bags and Pouches
      11.6.7 Sachets
      11.6.8 Kits or Packs
      11.6.9 Others
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific  Market Size Forecast by Applications
      11.10.1 Drug Manufacturing Companies
      11.10.2 Research Laboratories
      11.10.3 Clinical Research Organizations
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America  Analysis and Forecast
   12.1 Introduction
   12.2 Latin America  Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America  Market Size Forecast by Type
      12.6.1 Syringes
      12.6.2 Vials and Ampoules
      12.6.3 Blisters
      12.6.4 Tubes
      12.6.5 Bottles
      12.6.6 Bags and Pouches
      12.6.7 Sachets
      12.6.8 Kits or Packs
      12.6.9 Others
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America  Market Size Forecast by Applications
      12.10.1 Drug Manufacturing Companies
      12.10.2 Research Laboratories
      12.10.3 Clinical Research Organizations
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA)  Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA)  Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA)  Market Size Forecast by Type
      13.6.1 Syringes
      13.6.2 Vials and Ampoules
      13.6.3 Blisters
      13.6.4 Tubes
      13.6.5 Bottles
      13.6.6 Bags and Pouches
      13.6.7 Sachets
      13.6.8 Kits or Packs
      13.6.9 Others
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA)  Market Size Forecast by Applications
      13.10.1 Drug Manufacturing Companies
      13.10.2 Research Laboratories
      13.10.3 Clinical Research Organizations
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Clinical Trial Packaging Market: Competitive Dashboard
   14.2 Global Clinical Trial Packaging Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Bilcare
      14.3.2 Fisher Clinical Services
      14.3.3 WuXi AppTec
      14.3.4 PCI Pharma Services
      14.3.5 Almac Group
      14.3.6 PharMaterials
      14.3.7 PAREXEL
      14.3.8 Schreiner MediPharm
      14.3.9 Sharp Packaging
      14.3.10 The Coghlan Group
      14.3.11 Rubicon
      14.3.12 Westrock
      14.3.13 Xerimis
      14.3.14 Catalent
      14.3.15 Piramal Pharma Solutions
      14.3.16 Corden Pharma
      14.3.17 DMB Consultancy
      14.3.18 Körber Medipak Systems
      14.3.19 Sentry BioPharma
      14.3.20 NextPharma
      14.3.21 Mawdsleys

Our Trusted Clients

Contact Us